Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
AERI

Aerie Pharmaceuticals

$61.45

-1.5 (-2.38%)

08:41
10/16/17
10/16
08:41
10/16/17
08:41
Recommendations
Aerie Pharmaceuticals analyst commentary at Needham »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

AERI

Aerie Pharmaceuticals

$61.45

-1.5 (-2.38%)

07:44
10/16/17
10/16
07:44
10/16/17
07:44
Recommendations
Aerie Pharmaceuticals analyst commentary at Canaccord »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

AERI

Aerie Pharmaceuticals

$61.45

-1.5 (-2.38%)

07:36
10/16/17
10/16
07:36
10/16/17
07:36
Recommendations
Aerie Pharmaceuticals analyst commentary at Cantor Fitzgerald »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

Friday
AERI

Aerie Pharmaceuticals

$62.95

-1.35 (-2.10%)

14:20
10/13/17
10/13
14:20
10/13/17
14:20
Hot Stocks
Breaking Hot Stocks news story on Aerie Pharmaceuticals »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

  • 28

    Feb

AERI

Aerie Pharmaceuticals

$62.95

-1.35 (-2.10%)

13:58
10/13/17
10/13
13:58
10/13/17
13:58
Hot Stocks
Aerie announces FDA advisory committee vote in favor of Rhopressa »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

  • 28

    Feb

AERI

Aerie Pharmaceuticals

$62.95

-1.35 (-2.10%)

12:55
10/13/17
10/13
12:55
10/13/17
12:55
Periodicals
FDA panel votes 9-1 in favor of Aerie's Rhopressa, Bloomberg reports »

An FDA panel voted 9-1 in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

  • 28

    Feb

AERI

Aerie Pharmaceuticals

$62.95

-1.35 (-2.10%)

08:25
10/13/17
10/13
08:25
10/13/17
08:25
Conference/Events
FDA Dermatologic & Ophthalmic Drugs Advisory Committee to hold a meeting »

The Committee discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

  • 28

    Feb

AERI

Aerie Pharmaceuticals

$62.95

-1.35 (-2.10%)

07:09
10/13/17
10/13
07:09
10/13/17
07:09
Hot Stocks
Breaking Hot Stocks news story on Aerie Pharmaceuticals »

Aerie Pharm: FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

  • 28

    Feb

AERI

Aerie Pharmaceuticals

$62.95

-1.35 (-2.10%)

07:06
10/13/17
10/13
07:06
10/13/17
07:06
Hot Stocks
Aerie Pharmaceuticals stock trading halted ahead of FDA committee meeting »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

  • 28

    Feb

AERI

Aerie Pharmaceuticals

$62.95

-1.35 (-2.10%)

07:00
10/13/17
10/13
07:00
10/13/17
07:00
Hot Stocks
Breaking Hot Stocks news story on Aerie Pharmaceuticals »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

  • 28

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.